Clinical efficacy, safety and tolerability of BIO-C® (micronized Silymarin) as a galactagogue

Acta Biomedica de l'Ateneo Parmense

Volumn 79, Issue 3, 2008, Pages 205-210

  Di Pierro, Francesco ^a,c   Callegari, Alberto ^a   Carotenuto, Domenico ^b   Tapia, Marco Mollo ^b  

^a Velleja Research   (Italy)

^b UNIVERSIDAD NACIONAL MAYOR DE SAN MARCOS   (Peru)

^c Pharmacological and Clinical Research Based Company   (Italy)

Author keywords

BIO C ; Galactagogue; Silymarin

Indexed keywords

BIO C; PIULATTE; PLACEBO; SILYMARIN; UNCLASSIFIED DRUG; ANTIOXIDANT;

ARTICLE; BREAST FEEDING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DELIVERY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HERBAL MEDICINE; HUMAN; HUMAN EXPERIMENT; LACTATION; MILK PRODUCTION; NORMAL HUMAN; PATIENT COMPLIANCE; BREAST MILK; CHEMISTRY; COMPARATIVE STUDY; DRUG EFFECT; INFANT; NEWBORN; ORAL DRUG ADMINISTRATION; SAFETY; STATISTICAL ANALYSIS; TIME;

ADMINISTRATION, ORAL; ANTIOXIDANTS; BREAST FEEDING; DATA INTERPRETATION, STATISTICAL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; LACTATION; MILK, HUMAN; SAFETY; SILYMARIN; TIME FACTORS;

EID: 63049112752     PISSN: 03924203     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Puschner B, Galey FD, Holstege DM, Palazoglu M. Sweet clover poisoning in dairy cattle in California. J Am Vet Med Assoc 1998 15; 212 (6): 857-859 (Pubitemid 28236907)
2. Terrill TH, Mosjidis JA, Moore DA,e t al. Effect of pelleting on efficacy of sericea lespedeza hay as a natural dewormer in goats. Vet Parasitol 2007; 146 (1-2): 117-122
3. Tedesco D, Tava A, Galletti S, et al. Effects of silymarin, a natural hepatoprotector, in periparturient dairy cows. J Dairy Sci 2004; 87 (7): 2239-2247 (Pubitemid 38978827)
4. Vojtísek B, Hronová B, Hamrík J, Janková B. Milk thistle (Silybum marianum, L., Gaertn.) in the feed of ketotic cows. Vet Med (Praha) 1991; 36 (6): 321-330
5. Flora K, Hahn M, Rosen H, and Benner K. Milk Thistle for the therapy of liver disease. Am J Gastroenterol 1998; 93 (2): 139-146
6. Maitrejan M. The flavonolignan silybin and its hemisynthetic derivatives, a novel series of potential modulators of Pglicoprotein. Biorg Med Chem Lett 2000; 18: 34-39
7. Takahara E. Stimulatory effects of silybin on the DNA synthesis in partially hepatectomized rat livers: no response in epatoma and other malignant cell lines. Biochem Pharmacol 1986; 13: 21-25
8. Morazzoni P, Magistretti M, Giachetti C, Zanolo G. Comparative bioavailability of silipide a new flavanolignan complex, in rats. Europ J Drug Metabol Pharmacok 1992; 17 (1): 39-44.
9. Saller R, Brignoli R, Melzer J, Meier R. An updated systematic review with meta-analysis for the clinical evidence of silymarin. Forsch Komplement Med 2008; 15 (1): 9-20.
10. Anderson PO, Valdés V. A critical review of pharmaceutical galactagogues. Breastfeed Med 2007; 2 (4): 229-242 (Pubitemid 350274436)
11. European Pharmacopoeia 6.0, method reported in "Milk thistle dry extract, refined and standardized": 2426-2427
12. Gazák R, Walterová D, Kren V. Silybin and silymarin - new and emerging applications in medicine. Curr Med Chem 2007; 14 (3): 315-338 (Pubitemid 46313027)